companydata.dkcompanydata.dk

Frederiksstaden Pharma ApS: Financial statements 2025

CVR: 25630483

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986. The solvency ratio was 27.5%.

Gross Profit
DKK 61,605
Profit/Loss
DKK 139,819
Equity
DKK 237,986
Total Assets
DKK 864,452
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-62 t.140 t.238 t.0
2024--39 t.-51 t.98 t.0
2023--80 t.-82 t.149 t.0
2022-13 t.4 t.231 t.0
2021--666 t.-1.4 mio.227 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Frederiksstaden Pharma ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Frederiksstaden Pharma ApS appoints new auditorJul 21, 2025

As of July 21, 2025, KPMG P/S has been appointed auditor of Frederiksstaden Pharma ApS.

Auditor steps down at Frederiksstaden Pharma ApSJul 21, 2025

As of July 21, 2025, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of Frederiksstaden Pharma ApS.

Frederiksstaden Pharma ApS: The 2024 annual report is outMar 28, 2025

Frederiksstaden Pharma ApS has published its annual report for 2024. Gross profit came to DKK -39,059, and the net result was DKK -50,518.

About Frederiksstaden Pharma ApS

Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.

Source: annual report 2025, Danish Business Authority